Indiana Joins Fight Against Insulin Makers, PBMs Over Prices (2)

Indiana is the latest state to target insulin makers and the companies managing prescription drug benefits with a lawsuit alleging the corporations worked in tandem to artificially raise prices for diabetes patients.

The complaint, filed Tuesday by Indiana Attorney General Todd Rokita (R) in the Indiana Superior Court in Lake County, alleges insulin makers Novo Nordisk A/S and Sanofi SA have conspired with the nation’s top pharmacy benefit managers to use a complicated rebate system that has driven up the prices of life-saving insulin products, violating Indiana consumer sales and antitrust laws. The lawsuit specifically names PBMs CVS Caremark ...